| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/29/2026 | ±2.7% | -11.1% | under-priced |
| 04/22/2026 | ±3.4% | +10.8% | under-priced |
| 10/29/2025 | ±2.3% | -4.7% | under-priced |
| 07/31/2025 | ±2.0% | +3.6% | under-priced |
| 04/23/2025 | ±2.7% | -3.4% | under-priced |
| 10/29/2024 | ±2.1% | -0.5% | over-priced |
| 07/25/2024 | ±2.6% | +7.5% | under-priced |
| 04/24/2024 | ±2.0% | -4.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.60 | $2.0B | $333M |
| Q1 FY2026 | $1.05 | $1.9B | $228M |
| Q3 FY2025 | $0.90 | $1.9B | $200M |
| Q2 FY2025 | $1.28 | $2.1B | $283M |
Masco Corporation (MAS) reports in 72 days, with the next report estimated for 11/23/2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 5.8% on average — the market has tended to under-price MAS's earnings risk. Fundamentals into the print: EPS up 83.9% year-over-year, revenue up 10.6%. QuantLogix's live 5-factor engine currently reads MAS as a buy at 61/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →